Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this vaccine maker have returned +104.6% over the past month versus the Zacks S&P 500 composite's +3.3% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax belongs, has gained 0.9% over this period. Now the key question is: Where could the stock be headed in the near term?Although ...